Creative Pharma Technologies Private Limited, a active private limited company, was established on 10 March 2017 in Mumbai- 400063, Maharashtra, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U74999MH2017PTC292293. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹6.00 M and a paid-up capital of ₹5.10 M.
It upholds a compliant status. Its leadership includes Mayank Sumatiprakash Jain (Director), Pawan Solanki (Additional Director), Sumatiprakash Madanlal Jain (Director). Past directors included Pawan Solanki. It holds ₹5.00 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 130,Shanta Ind Premises Cs Ltd, Ib Patel Road, Nf Harerama Estate Goregaon (East), Mumbai- 400063, Maharashtra, 400063.
U74999MH2017PTC292293
292293
10 March 2017
₹6.00 M
₹5.10 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Creative Pharma Technologies Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Mayank Sumatiprakash Jain | Director | 10 Mar 2017 | Current |
| Pawan Solanki | Additional Director | 05 Apr 2025 | Current |
| Sumatiprakash Madanlal Jain | Director | 10 Mar 2017 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 30 Sep 2024 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Creative Pharma Technologies Private Limited, for the financial year ended 2024, experienced modest growth in revenue, with a 2.86% increase. The company also saw a substantial fall in profitability, with a 23.83% decrease in profit. The company's net worth Soared by an impressive increase of 23.89%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2024, Creative Pharma Technologies had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹50,000,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 23 Nov 2022 | Others | ₹5.00 Cr | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Creative Pharma Technologies, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Creative Pharma Technologies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Creative Pharma Technologies's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Pawan Solanki was appointed as a Additional Director was appointed as a Additional Director on 05 Apr 2025 & has been associated with this company since 7 months 26 days . was recorded as a recent event.
Progress on Creative Pharma Technologies Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
Creative Pharma Technologies Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was recorded as a recent event.
Progress on A charge with Others amounted to Rs. 50.00 M with Charge ID 100656025 was registered on 23 Nov 2022. was documented.
The activity Mayank Sumatiprakash Jain was appointed as a Director was appointed as a Director on 10 Mar 2017 & has been associated with this company since 8 years 8 months . was completed.
Progress on Sumatiprakash Madanlal Jain was appointed as a Director was appointed as a Director on 10 Mar 2017 & has been associated with this company since 8 years 8 months . was documented.
The CIN of Creative Pharma Technologies Private Limited is U74999MH2017PTC292293.
Creative Pharma Technologies Private Limited is headquartered at 130,Shanta Ind Premises Cs Ltd, Ib Patel Road, Nf Harerama Estate Goregaon (East), Mumbai- 400063, Maharashtra, 400063.
Creative Pharma Technologies Private Limited was incorporated on 10 March 2017.
The current directors of Creative Pharma Technologies Private Limited are
The primary industry of Creative Pharma Technologies Private Limited is Trade.
Creative Pharma Technologies Private Limited is unlisted.
The authorized capital of Creative Pharma Technologies Private Limited is ₹6.00 M, and the paid-up capital is ₹5.10 M.
The compliance status of Creative Pharma Technologies Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX